Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Effects of elevated tacrolimus trough levels in association with infectious enteritis on graft function in renal transplant recipients.

Nakamura A, Amada N, Haga I, Tokodai K, Kashiwadate T.

Transplant Proc. 2014;46(2):592-4. doi: 10.1016/j.transproceed.2013.11.040.

PMID:
24656020
2.

Severe elevations of FK506 blood concentration due to diarrhea in renal transplant recipients.

Sato K, Amada N, Sato T, Miura S, Ohashi Y, Sekiguchi S, Satomi S, Okazaki H.

Clin Transplant. 2004 Oct;18(5):585-90.

PMID:
15344965
3.

Two- to three-fold increase in blood tacrolimus (FK506) levels during diarrhea in liver-transplanted children.

Berengue JI, López-Espinosa JA, Ortega-López J, Sánchez-Sánchez L, Castilla-Valdes P, Asensio-Llorente M, Margarit-Creixell C.

Clin Transplant. 2003 Jun;17(3):249-53.

PMID:
12780676
4.

Increased tacrolimus trough levels in association with severe diarrhea, a case report.

Asano T, Nishimoto K, Hayakawa M.

Transplant Proc. 2004 Sep;36(7):2096-7.

PMID:
15518758
5.

Cryptosporidium enteritis in solid organ transplant recipients: multicenter retrospective evaluation of 10 cases reveals an association with elevated tacrolimus concentrations.

Bonatti H, Barroso LF 2nd, Sawyer RG, Kotton CN, Sifri CD.

Transpl Infect Dis. 2012 Dec;14(6):635-48. doi: 10.1111/j.1399-3062.2012.00719.x. Epub 2012 Feb 19.

PMID:
22340660
6.

Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.

Katari SR, Magnone M, Shapiro R, Jordan M, Scantlebury V, Vivas C, Gritsch A, McCauley J, Starzl T, Demetris AJ, Randhawa PS.

Clin Transplant. 1997 Jun;11(3):237-42.

7.

Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.

Cho JH, Yoon YD, Park JY, Song EJ, Choi JY, Yoon SH, Park SH, Kim YL, Kim CD.

Transplant Proc. 2012 Jan;44(1):109-14. doi: 10.1016/j.transproceed.2011.11.004.

PMID:
22310591
8.

Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation.

Anglicheau D, Flamant M, Schlageter MH, Martinez F, Cassinat B, Beaune P, Legendre C, Thervet E.

Nephrol Dial Transplant. 2003 Nov;18(11):2409-14.

9.

Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.

Bolin P Jr, Shihab FS, Mulloy L, Henning AK, Gao J, Bartucci M, Holman J Jr, First MR; OPTIMA Study Group.

Transplantation. 2008 Jul 15;86(1):88-95. doi: 10.1097/TP.0b013e31817442cf.

PMID:
18622283
10.

Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation.

Lo A, Egidi MF, Gaber LW, Shokouh-Amiri MH, Nazakatgoo N, Fisher JS, Gaber AO.

Clin Transplant. 2004 Feb;18(1):53-61.

PMID:
15108771
11.

Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients.

Richards KR, Hager D, Muth B, Astor BC, Kaufman D, Djamali A.

Transplantation. 2014 May 27;97(10):986-91. doi: 10.1097/TP.0000000000000149.

PMID:
24784360
12.

Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.

Kolonko A, Chudek J, Wiecek A.

Transplant Proc. 2011 Oct;43(8):2950-3. doi: 10.1016/j.transproceed.2011.07.014.

PMID:
21996198
13.

Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients.

Venkataramanan R, Shaw LM, Sarkozi L, Mullins R, Pirsch J, MacFarlane G, Scheller D, Ersfeld D, Frick M, Fitzsimmons WE, Virji M, Jain A, Brayman KL, Shaked A.

J Clin Pharmacol. 2001 May;41(5):542-51.

PMID:
11361051
14.

Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.

Meçule A, Tinti F, Poli L, Bachetoni A, Umbro I, Nofroni I, Lai Q, Pretagostini R, Berloco PB, Mitterhofer AP.

Transplant Proc. 2011 May;43(4):1024-7. doi: 10.1016/j.transproceed.2011.02.049.

PMID:
21620042
15.

Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.

Ma MK, Kwan LP, Mok MM, Yap DY, Tang CS, Chan TM.

Ren Fail. 2013 Aug;35(7):942-5. doi: 10.3109/0886022X.2013.808134. Epub 2013 Jul 2.

PMID:
23815459
16.

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients.

Haufroid V, Mourad M, Van Kerckhove V, Wawrzyniak J, De Meyer M, Eddour DC, Malaise J, Lison D, Squifflet JP, Wallemacq P.

Pharmacogenetics. 2004 Mar;14(3):147-54.

PMID:
15167702
17.

Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients.

Heavner MS, Tichy EM, Yazdi M, Formica RN Jr, Kulkarni S, Emre S.

Am J Health Syst Pharm. 2013 Sep 1;70(17):1507-12. doi: 10.2146/ajhp120783.

PMID:
23943182
18.

Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients.

Nasiri-Toosi Z, Dashti-Khavidaki S, Nasiri-Toosi M, Khalili H, Jafarian A, Irajian H, Abdollahi A, Sadrai S.

Exp Clin Transplant. 2012 Dec;10(6):586-91. doi: 10.6002/ect.2012.0032. Epub 2012 Jul 5.

19.

Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipients.

Kim IW, Moon YJ, Ji E, Kim KI, Han N, Kim SJ, Shin WG, Ha J, Yoon JH, Lee HS, Oh JM.

Eur J Clin Pharmacol. 2012 May;68(5):657-69. doi: 10.1007/s00228-011-1182-5. Epub 2011 Dec 20.

PMID:
22183771
20.

Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics.

Israni AK, Riad SM, Leduc R, Oetting WS, Guan W, Schladt D, Matas AJ, Jacobson PA; DeKAF Genomics Investigators.

Transpl Int. 2013 Oct;26(10):982-9. doi: 10.1111/tri.12155. Epub 2013 Jul 24.

Items per page

Supplemental Content

Write to the Help Desk